Cardinal Health, Inc. (NYSE:CAH) Stock Holdings Lessened by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 20.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 377,117 shares of the company’s stock after selling 94,271 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Cardinal Health were worth $44,470,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of CAH. Frazier Financial Advisors LLC increased its stake in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares in the last quarter. Promus Capital LLC purchased a new position in shares of Cardinal Health in the fourth quarter worth approximately $30,000. AM Squared Ltd acquired a new stake in shares of Cardinal Health during the third quarter valued at approximately $33,000. Kentucky Trust Co purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $41,000. Finally, HHM Wealth Advisors LLC boosted its stake in Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after purchasing an additional 144 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $126.87 on Thursday. The stock has a market capitalization of $30.65 billion, a P/E ratio of 23.67, a P/E/G ratio of 1.49 and a beta of 0.66. The business has a 50-day moving average of $125.99 and a two-hundred day moving average of $119.14. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.59%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Citigroup boosted their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Wells Fargo & Company increased their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Mizuho began coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.